EdgePoint Investment Group’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-1,613,575
Closed -$136M 47
2017
Q2
$136M Sell
1,613,575
-340,024
-17% -$27.4M 2.15% 17
2017
Q1
$158M Sell
1,953,599
-1,695,479
-46% -$133M 2.67% 17
2016
Q4
$274M Sell
3,649,078
-16,607
-0.5% -$1.2M 4.61% 7
2016
Q3
$248M Buy
3,665,685
+666,101
+22% +$44.7M 4.06% 12
2016
Q2
$204M Sell
2,999,584
-45,063
-1% -$3.31M 3.56% 16
2016
Q1
$220M Buy
3,044,647
+420,690
+16% +$27.6M 3.81% 12
2015
Q4
$177M Buy
2,623,957
+290,010
+12% +$20.3M 3.43% 13
2015
Q3
$151M Buy
2,333,947
+569,020
+32% +$42M 3% 15
2015
Q2
$144M Sell
1,764,927
-18,179
-1% -$1.4M 2.81% 16
2015
Q1
$123M Buy
+1,783,106
New +$129M 2.73% 19

Other funds holding EMN

EdgePoint Investment Group's EMN Position: Q3 2017 in Review

EdgePoint Investment Group sold out of Eastman Chemical (EMN) in Q3 2017, closing a stake of 1,613,575 shares — an estimated $136M sold.

EdgePoint Investment Group first reported a position in EMN in Q1 2015 and held it in 10 quarters. The position peaked at $274M in Q4 2016. 622 funds tracked by Wall St. Rank hold EMN as of Q3 2017.

  • EdgePoint Investment Group reported no remaining Eastman Chemical position as of Q3 2017 after selling out during the quarter.
  • EdgePoint Investment Group sold 1,613,575 Eastman Chemical shares in Q3 2017, an estimated $136M.
  • EdgePoint Investment Group first reported a position in Eastman Chemical in Q1 2015 and held it in 10 quarters.
  • EdgePoint Investment Group's Eastman Chemical position peaked at $274M in Q4 2016.
  • 622 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2017.

Based on EdgePoint Investment Group's 13F filing for Q3 2017, filed 14 Nov 2017.